In the US, 1 in 3, or 23 million eligible people are not screened for colon cancer.
As a consequence, 60% of colon cancer cases are diagnosed at a late stage, when the cancer has already spread and treatment becomes more challenging.
For those people who have a history of not completing screening by guideline recommended methods, there is now a blood test. Epi proColon is the first and only FDA approved blood test for colon cancer screening. Benefits of Epi proColon include:
• No pretest preparation
• No stool handling
• No dietary or medication restrictions
• Available through national laboratories